According to a new survey, americans are largely opposed to President Donald trump’s proposed tariffs on steel and aluminum imports.
Tariffs, which are used for import duties, will be levied on steel imports and 10% of aluminum plus 25%. Economists, republican lawmakers and industries using these metals have warned of the potentially harmful effects.
The public seems to agree. Only 31 percent of the new Quinnipiac university survey supported the tariff, while 50 percent opposed it.
Breaking the survey results:
Fifty-eight percent of republicans supported the tariff, while 20 percent opposed it. Republican congressional leaders such as house speaker Paul Ryan oppose Mr. Trump’s proposals.
Twenty-eight percent of independents supported the tariff, while 55 percent opposed it.
Thirty-six percent said tariffs would be bad for American jobs.
Twenty-six percent said they would be a good job. According to a new study, tariffs would cost the United States a net cost of about $146,000.
The planned tariffs have sparked warnings of retaliation from other countries, including Allies such as the European Union and Canada, raising fears of a tit-for-tat trade war.
Trump played down those concerns in a tweet Friday, saying “a trade war is good and easy to win.”
Americans seem to disagree with the President’s statement,
64 per cent disagreed with Mr Trump’s claim that trade war was good and could be won.
Twenty-eight percent said they agreed with the President’s assessment.
Qunny skin reaction university poll, vice minister of Tim malloy said in a statement: “import tariffs, smariff said, see the punishment other countries voters will cause more damage in the domestic.”
Thirty-four percent of respondents said they approve of trump’s handling of general trade, while 54 percent said they disagreed.
The CVS health plan is to finance the $69 billion acquisition of antai, a giant $40 billion bond.
The sale marks the company’s biggest corporate debt financing in more than two years and is the third largest in history. It is a tough time for investment-grade fixed-income markets, and the worst year in decades is over.
CVS’s large bond issue will be carried out as interest rates remain near record lows. But that will soon change as the fed continues to tighten monetary policy. The prospect of higher interest rates explains why CVS has decided to act now, with interest rates still relatively attractive.
In addition to providing 30-year bonds, all bonds will contain special mandatory redemption clauses, if Aetna deal is not yet over before September 3, 2019, requires the CVS debt is extracted by the price of 101 cents, a financial times reported.
Considering that Aetna has not yet received regulatory approval, it is a calculated risk.
Investors were worried about Makan Delrahim, the new antitrust chief of the justice department, as early as December, when the deal was announced. In the short term, he is less willing to accept so-called “vertical” mergers, which involve a combination of two companies’ different positions in the same supply chain.
However, the merger is expected to close in the second half of this year. CVS’s decision to launch such a large bond offering suggests that the deal will eventually be approved.
CVS shares fell 1.4% on Tuesday afternoon.